Source: Annual Congress 2011 - Chest physiotherapy and breathing retraining



Rating:

Share or cite this content

Citations should be made in the following way:
R. Johnston, F. Shaw, R. Wilson, M. Loebinger, L. Flude (London, United Kingdom). Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasis. Eur Respir J 2011; 38: Suppl. 55, 2978

Member's Comments

Berndt Roman - 27.11.2011 01:35
Thank you for the presentation and please do not forget to send me a pdf :-) Roman

Related content which might interest you: Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home? Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Frequent outpatient exacerbations of non cystic fibrosis bronchiectasis leads to impaired health related quality of life Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis Source: Eur Respir J 2013; 42: 371-379 Year: 2013 Effect of short-term inhalation of warm saline atomised gas on patients with non-cystic fibrosis bronchiectasis Source: ERJ Open Res, 6 (1) 00130-2019; 10.1183/23120541.00130-2019 Year: 2020 Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1) Source: Eur Respir J 2010; 35: 118-123 Year: 2010 Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium Source: Eur Respir J 2002; 19: 209-216 Year: 2002 Increase in health status after 12 days treatment with inhaled mannitol in patients with bronchiectasis Source: Eur Respir J 2003; 22: Suppl. 45, 430s Year: 2003 RCT Abstract - The effect of inhaled hypertonic saline on lung structure in preschool children with cystic fibrosis Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 The efficacy and tolerability of inhaled hypertonic saline in children with cystic fibrosis Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 The use of home intravenous antibiotics in adult non-CF bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Health-related quality of life in non-cystic fibrosis bronchiectasis children Source: Annual Congress 2011 - Rare lung diseases in children Year: 2011 Hospital admissions are linked to a poor health related quality of life in patients with non cystic fibrosis bronchiectasis Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007 Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by pseudomonas aeruginosa Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Patients’ expectations and quality of life before introduction of pirfenidone used in idiopathic pulmonary fibrosis. Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010